Lincoln, MA, United States of America

Rongzhen Lu

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2010-2018

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Rongzhen Lu

Introduction

Rongzhen Lu is an accomplished inventor based in Lincoln, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of novel compounds and methods for modulating immune responses. With a total of two patents to his name, his work has the potential to impact the treatment of various inflammatory and immune disorders.

Latest Patents

Rongzhen Lu's latest patents include "Compositions and methods for modulating c-Rel-dependent cytokine production." This invention focuses on methods to modulate cytokine production without significantly altering the expression levels of NFκB and/or the amount of IκB. Additionally, he has developed a patent titled "Pyrimidine compounds and uses thereof." This invention features pyrimidine compounds that inhibit the production of IL-12, IL-23, and IL-27, which are crucial for treating disorders associated with their overproduction or misregulation.

Career Highlights

Throughout his career, Rongzhen Lu has worked with notable companies such as Synta Pharmaceuticals Corporation and Madrigal Pharmaceuticals, Inc. His experience in these organizations has allowed him to collaborate on various innovative projects that advance the field of biotechnology.

Collaborations

Rongzhen Lu has collaborated with several professionals in his field, including Yumiko Wada and Albert Y Hsia. These collaborations have contributed to the development of his patents and the advancement of research in immune modulation.

Conclusion

Rongzhen Lu's innovative work in biotechnology, particularly in the modulation of immune responses, showcases his significant contributions to the field. His patents reflect a commitment to addressing critical health issues through scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…